FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387633998> ?p ?o ?g. }

• W4387633998 endingPage "e35610" @default.
• W4387633998 startingPage "e35610" @default.
• W4387633998 abstract "Helicobacter pylori (H pylori) can cause gastritis, peptic ulcers, gastric cancer, and many other gastrointestinal diseases. The 14-day neo-dual therapy for H pylori is considered by most countries to have good eradication rates, while the 7- and 10-day studies have been more widely explored, however, we find that their results are different. The applicability of the shorter and less expensive 10-day neo-dual therapy to our country has not yet been confirmed.The patients were divided into 3 groups of 200 each by randomization method. Group A: patients received vonoprazan 20 mg, bid + amoxicillin(1 g), tid, for 14 days. Group B: vonoprazan (20 mg) bid + amoxicillin (1 g) tid, duration of treatment is 10 days, group C: rabeprazole (20 mg) bid + bismuth potassium citrate tablets/tinidazole tablets/clarithromycin tablets, combined package (4.2 g), bid, duration of treatment 14 days. The main comparisons were H pylori eradication rate, adverse drug reaction profile and cost-effect ratio in each group.The eradication rates of groups A, B, and C were 92.5%, 91.6%, and 80.1%, respectively. There was no significant difference in the eradication rates of groups A and B (P > .05), groups A and B had statistically significantly better eradication rates than group C (P < .05). The incidence of adverse reactions in groups A, B, and C was 9.5%, 8.5%, and 17.0%, respectively. There was no difference in the incidence of adverse reactions between A and B: (P > .05), The incidence of adverse reactions was statistically significantly lower in groups A and B than in group C (P < .05). Logistic regression analysis showed nonsmokers had a higher eradication rate (OR 2.587, 95% CI: 1.377-4.859, P = .003), and taller patients were more likely to have successful eradication (OR 1.052, 95% CI: 1.008-1.097, P = .020). Group B had the lowest cost-benefit analysis results.Group B had an acceptable eradication rate, the lowest incidence of adverse effects, and the lowest cost analysis. Eradication is more likely to be successful in patients who do not smoke and in those who are taller." @default.
• W4387633998 created "2023-10-14" @default.
• W4387633998 creator A5000949028 @default.
• W4387633998 creator A5015893806 @default.
• W4387633998 creator A5029837334 @default.
• W4387633998 creator A5043276696 @default.
• W4387633998 date "2023-10-13" @default.
• W4387633998 modified "2023-10-18" @default.
• W4387633998 title "A randomized clinical study on the efficacy of vonoprazan combined with amoxicillin duo regimen for the eradication of Helicobacter pylori" @default.
• W4387633998 cites W2050132242 @default.
• W4387633998 cites W2072080364 @default.
• W4387633998 cites W2089634709 @default.
• W4387633998 cites W2149835202 @default.
• W4387633998 cites W2323860286 @default.
• W4387633998 cites W2408731739 @default.
• W4387633998 cites W2419322912 @default.
• W4387633998 cites W2523141852 @default.
• W4387633998 cites W2527848138 @default.
• W4387633998 cites W2613485273 @default.
• W4387633998 cites W2730954014 @default.
• W4387633998 cites W2790522681 @default.
• W4387633998 cites W2942383056 @default.
• W4387633998 cites W2971966449 @default.
• W4387633998 cites W2998847875 @default.
• W4387633998 cites W3016500486 @default.
• W4387633998 cites W3164185201 @default.
• W4387633998 cites W3186060719 @default.
• W4387633998 cites W3211189042 @default.
• W4387633998 cites W3215405182 @default.
• W4387633998 cites W4200162900 @default.
• W4387633998 cites W4206916133 @default.
• W4387633998 cites W4210441536 @default.
• W4387633998 cites W4225126559 @default.
• W4387633998 cites W4234088805 @default.
• W4387633998 cites W4281872253 @default.
• W4387633998 doi "https://doi.org/10.1097/md.0000000000035610" @default.
• W4387633998 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37832048" @default.
• W4387633998 hasPublicationYear "2023" @default.
• W4387633998 type Work @default.
• W4387633998 citedByCount "0" @default.
• W4387633998 crossrefType "journal-article" @default.
• W4387633998 hasAuthorship W4387633998A5000949028 @default.
• W4387633998 hasAuthorship W4387633998A5015893806 @default.
• W4387633998 hasAuthorship W4387633998A5029837334 @default.
• W4387633998 hasAuthorship W4387633998A5043276696 @default.
• W4387633998 hasBestOaLocation W43876339981 @default.
• W4387633998 hasConcept C120665830 @default.
• W4387633998 hasConcept C121332964 @default.
• W4387633998 hasConcept C126322002 @default.
• W4387633998 hasConcept C197934379 @default.
• W4387633998 hasConcept C2776409635 @default.
• W4387633998 hasConcept C2776962512 @default.
• W4387633998 hasConcept C2777396551 @default.
• W4387633998 hasConcept C2777785397 @default.
• W4387633998 hasConcept C2778043744 @default.
• W4387633998 hasConcept C2779116819 @default.
• W4387633998 hasConcept C2779390736 @default.
• W4387633998 hasConcept C2779708577 @default.
• W4387633998 hasConcept C2780626017 @default.
• W4387633998 hasConcept C2780656511 @default.
• W4387633998 hasConcept C2781413609 @default.
• W4387633998 hasConcept C501593827 @default.
• W4387633998 hasConcept C61511704 @default.
• W4387633998 hasConcept C71924100 @default.
• W4387633998 hasConcept C86803240 @default.
• W4387633998 hasConcept C89423630 @default.
• W4387633998 hasConcept C90924648 @default.
• W4387633998 hasConceptScore W4387633998C120665830 @default.
• W4387633998 hasConceptScore W4387633998C121332964 @default.
• W4387633998 hasConceptScore W4387633998C126322002 @default.
• W4387633998 hasConceptScore W4387633998C197934379 @default.
• W4387633998 hasConceptScore W4387633998C2776409635 @default.
• W4387633998 hasConceptScore W4387633998C2776962512 @default.
• W4387633998 hasConceptScore W4387633998C2777396551 @default.
• W4387633998 hasConceptScore W4387633998C2777785397 @default.
• W4387633998 hasConceptScore W4387633998C2778043744 @default.
• W4387633998 hasConceptScore W4387633998C2779116819 @default.
• W4387633998 hasConceptScore W4387633998C2779390736 @default.
• W4387633998 hasConceptScore W4387633998C2779708577 @default.
• W4387633998 hasConceptScore W4387633998C2780626017 @default.
• W4387633998 hasConceptScore W4387633998C2780656511 @default.
• W4387633998 hasConceptScore W4387633998C2781413609 @default.
• W4387633998 hasConceptScore W4387633998C501593827 @default.
• W4387633998 hasConceptScore W4387633998C61511704 @default.
• W4387633998 hasConceptScore W4387633998C71924100 @default.
• W4387633998 hasConceptScore W4387633998C86803240 @default.
• W4387633998 hasConceptScore W4387633998C89423630 @default.
• W4387633998 hasConceptScore W4387633998C90924648 @default.
• W4387633998 hasIssue "41" @default.
• W4387633998 hasLocation W43876339981 @default.
• W4387633998 hasLocation W43876339982 @default.
• W4387633998 hasOpenAccess W4387633998 @default.
• W4387633998 hasPrimaryLocation W43876339981 @default.
• W4387633998 hasRelatedWork W1481539727 @default.
• W4387633998 hasRelatedWork W1978477519 @default.
• W4387633998 hasRelatedWork W2239438304 @default.
• W4387633998 hasRelatedWork W2347647357 @default.
• W4387633998 hasRelatedWork W2350256963 @default.

• next